Biography
Taylor McDowell is a regulatory and transactional attorney in the Healthcare and Corporate & Securities, Healthcare, and Investment Funds practice groups at Jackson Walker. In his healthcare practice, Taylor represents hospital districts, private hospitals, physicians and group practices, and healthcare startup companies in the role of outside general counsel in various healthcare transactional and regulatory compliance matters involving managed care contracts, physician recruitment agreements, physician employment agreements, and non-profit and 162.001(b) entity formation. Taylor has a particular interest in the emerging telehealth industry, and he regularly counsels clients in connection with the development of telemedicine platforms. He also advises clients on cybersecurity issues pertaining to HIPAA compliance and other applicable data security laws and regulations.
In his corporate practice, Taylor represents public and private companies, state institutions, bank holding companies, and investor groups in a variety of engagements, including public and private offerings and mergers and acquisitions. Taylor has also represented startup companies in connection with entity formation, corporate governance, seed and series rounds of funding, and e-Commerce issues concerning Terms and Conditions and Privacy Policies.
Taylor has written a number of academic papers on topics including healthcare, corporate transactions and antitrust, and market-based environmentalism that have been published in law journals with Harvard, Georgetown, and the University of Virginia. He has also co-hosted a number of national webinars pertaining to HIPAA compliance and regulatory advice for handling medical records. Taylor also works on a number of pro bono cases and has drafted asylum petitions for refugees, helped institute microfinance programs for international non-profit organizations, and has assisted with contract disputes and mediation for local non-profit corporations. Taylor currently serves on the Board of Directors for Abundant Life Foundation and previously served on the Board of El Buen Samaritano Episcopal Mission.
Education
B.S., International Affairs, with highest honors, Georgia Institute of Technology
J.D., University of Virginia School of Law
- Editorial Board, Virginia Law & Business Review
- Entrepreneurial Law Clinic
- Virginia Innocence Project
- University Judiciary Committee
- Phi Delta Phi Legal Honor Society
Bar Admissions
Texas
- Served on legal team advising the owners of the restaurant chain Whataburger in the sale of a majority interest to BDT Capital Partners, LLC, a premier private equity firm and merchant bank.
- Assisted as legal counsel for Acelity, Inc., a leading global medical technology company, and its KCI subsidiaries in connection with the sale of their business to 3M for approximately $6.725 billion.
- Represented a Texas-based healthcare software company in the $20 million sale of its equity interests to a German-based software company and the structuring of a $6 million earn-out for company executives.
- Served as legal counsel to a Texas-based bank holding company in connection with the pricing of its initial public offering of 2,300,000 shares of its common stock at $21 per share.
- Represented a Texas-based bank holding company in its acquisition by a multi-state bank holding company in a transaction of more than 2 million shares of stock and cash consideration of more than $30 million.
- Represented an institutional investor in connection with its initial $285 million equity investment and additional $141 million equity investment into a private equity investment fund.
- Served as legal counsel in connection with the formation of a $21.5 million private equity investment fund.
- Served as legal counsel to a Texas hospital district in the development of its multi-million dollar telemedicine platform.
- Represented an institutional client in the multi-million dollar sale and transfer on the secondary market of its limited partnership interests in private investment funds.
- Represented a healthcare facility in the multi-million dollar acquisition of substantially all of the assets of an urgent care center.
- Represented an oncology team in transitioning their existing practice to form a new practice entity.
- Represented environmental technology start-up company in connection with a Convertible Note Offering of $1 million.
- Assisted as Texas and regulatory counsel for a Houston-based multispecialty clinic system in the negotiation and closing of a substantial strategic equity investment.
- University of Virginia School of Law – Pro Bono Program Certificate of Recognition
- American Council on the Teaching of Foreign Language – Spanish Language Proficiency
- “Staying Compliant While Granting Access of Medical Records to Patient’s Family and Caregivers,” Lorman OnDemand Course (2022).
- “The Most Common Legal Mistakes Made When Handling Medical Records and How to Avoid Them,” Lorman OnDemand Course (2022).
- “Mandatory Health Savings Accounts and the Need for Consumer-Driven Healthcare,” Georgetown Journal of Law & Public Policy (2018).
- “Changing the Game: Remedying the Deficiencies of Baseball’s Antitrust Exemption in the Minor Leagues,” Harvard Journal of Sports & Entertainment Law (2018).
- “The Case for Cap-and-Trade: California’s Battle for Market-Based Environmentalism,” Virginia Environmental Law Journal (2017).
- St. David’s Episcopal Day School, Member of the Board of Directors
- El Buen Samaritano, Member of the Board of Directors
- American Society for the Prevention of Cruelty to Animals
- Virginia Innocence Project
- Volunteer Legal Services of Central Texas
- Valley League Baseball – Operations Manager for the Charlottesville Tom Sox
April 25, 2023
InsightsKey Considerations for Clinical Investigators When Negotiating Clinical Trial Agreements
By Nicholas J. Diamond and Taylor McDowell
Clinical trials are an essential component of the research architecture for developing new drugs and devices. Research institutions and their clinical investigators play an important role in supporting drug and device manufacturers—the clinical trial sponsors—in developing the data and evidence required to support regulatory submissions.
March 4, 2022
InsightsTexas Court Strikes Independent Dispute Resolution Processes Within the No Surprises Act Final Rule – Implications for Healthcare Providers and Facilities
By Taylor McDowell
On February 23, 2022, the Eastern District of Texas – Tyler Division determined that certain provisions concerning the independent dispute resolution (IDR) processes in the interim final rule issued pursuant to the No Surprises Act were in conflict with the Act and must be set aside under the Administrative Procedure Act.
March 8, 2021
Client ResultsJackson Walker Advises Kamada in Acquiring FDA-Licensed Plasma Collection Center
Marisela Gonzalez and Virginia Mimmack led a Jackson Walker team advising Kamada Ltd. in its acquisition of Blood and Plasma Research, Inc. With the acquisition, Kamada enters the U.S. plasma collection market and advances its strategic goal to become a fully integrated specialty plasma company.
December 17, 2020
InsightsUnpacking the COVID-19 Vaccine Distribution: A Bright Spot During a Dark Winter
The announcement of regulatory approval of new COVID-19 vaccines brought hope for the holiday season and the new year.
March 20, 2020
InsightsTelehealth: A Powerful Tool in Fighting COVID-19 Emergency-Driven Waivers and Payment Parity Requirements
In response to the Coronavirus (COVID-19) national public health emergency, government agencies have taken steps to temporarily relax certain regulatory requirements regarding telemedicine technology and insurance coverage.
March 3, 2020
Client ResultsJackson Walker Healthcare Team Serves as Chief Texas Counsel for Kelsey-Seybold in Strategic Equity Investment by TPG Capital
Under the terms of the agreement, Kelsey-Seybold remains fully owned and governed by physicians. Additional terms were not disclosed.
August 12, 2019
Client ResultsJeff Drummond and Taylor McDowell Represent Oncology Team in Transitioning Practice to Verdi Oncology
Jackson Walker represented Dr. Jivesh Sharma and Dr. Amy Cripps in transitioning their practices at NexGen Oncology into a new practice entity, the Verdi Cancer and Research Center of Texas.
June 7, 2018
Client ResultsJackson Walker Represents Integrity Bancshares in Sale to Independent Bank Group
Jackson Walker represented Integrity Bancshares, Inc., the holding company of Integrity Bank, in the sale of its business to Independent Bank Group, Inc., the holding company of a commercial bank operating in Texas and Colorado.
May 9, 2018
Client ResultsCorporate Group Represents Spirit of Texas Bancshares, Inc. in IPO
Jackson Walker represented Spirit of Texas Bancshares, Inc. (STXB) in its initial public offering of 2,300,000 shares of common stock at $21 per share, before underwriting discounts and commissions.